FDA Pulls List Related To Meningitis Outbreak
DALLAS (CBS 11 NEWS) – The U.S. Food and Drug Administration admitted to making a big mistake Monday regarding the national meningitis scare and the company at the center of the deadly outbreak. The agency released a list online that included several more medical facilities across the country, including some in North Texas, that received medicines from the New England Compounding Center.
That information was updated a few hours later, however, to include a disclaimer. “NOTE: FDA has found some technical problems with the list and the data are incorrect. FDA is working to correct the list and will re-post when we are sure it is accurate,” the FDA’s website says. Click here to check out the FDA information online.
Before it was pulled down, the following facilities from Dallas, Plano, Fort Worth, Mansfield and Corsicana appeared on the FDA’s list.
- Our Children’s House at Baylor in Dallas
- Cosmetic and Maxillofacial Surgery Center in Dallas
- Dallas Back Pain Management
- Dallas Plastic Surgery
- D. Douglas Lorimer, M.D. in Fort Worth
- Texas Health Harris Methodist
- Southlake Mansfield Surgery Center in Mansfield
- Navarro Regional Hospital in Corsicana
When the list was publicized, CBS 11 News started making phone calls to the named locations, asking about the medications received. That is when it became apparent that the information was incorrect. It is unclear which of these North Texas facilities, if any, received the drug directly linked to the meningitis outbreak, or what medications they may have received from the New England Compounding Center. That will become clear when the FDA updates its online data.
Officials with Baylor Health Care System issued a statement Monday saying that it “has confirmed our pharmacies did not receive or administer any epidural steroid injections from the manufacturer of the lots identified in the recent DCD investigation of meningitis outbreak.”
The New England Compounding Center is responsible for making the steroid linked to the meningitis outbreak, which has resulted in 23 deaths and nearly 300 illnesses across the nation. The company initially recalled the steroid and later expanded that recall to all of its products.
Also Check Out: